In today's episode, Dr. Mark Holthouse dives into the fears surrounding breast cancer and hormone replacement therapy, separating myth from evidence with a critical look at the real data. Our expert speaker unpacks the latest clinical trials and position statements, clarifying the nuanced relationship between various hormone therapies and breast cancer risk.
We’ll explore what the research says about synthetic versus bioidentical hormones, address common patient concerns, and provide actionable insights for risk assessment and individualized care.
This episode delivers an integrative approach to hormone therapy and breast cancer, bridging the gap between scientific literature and real-world practice.
To enroll in the Sex Steroid Optimization Master Class with Dr. Mark Holthouse, go to https://pages.kharrazianinstitute.com/holthouse-hormone
To become a Certified Functional Medicine practitioner, visit https://kharrazianinstitute.com/. Try our 7-day free trial, no credit card required.
00:00 WHI study on hormone therapy
04:45 Hormone therapy risks discussion
07:58 Discussing natural vs synthetic HRT
13:11 Transdermal hormone therapy studies
17:55 Rethinking full-fat dairy for women
21:11 Time restricted eating for women
22:57 Assessing breast cancer risk
25:30 Understanding genetic risk factors
29:37 Evaluating breast cancer risk factors